Effects of Treatment of PTSD on Reduced Recall for Fear Extinction
Effects of Treatment of Post-traumatic Stress Disorder on Reduced Recall for Fear Extinction
1 other identifier
interventional
25
1 country
1
Brief Summary
This preliminary study will examine the differential effects of rTMS on the recall of extinction of conditioned fear in patients suffering from PTSD (post-traumatic stress disorder ) compared with subjects without PTSD but with high risk of relapse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2010
CompletedFirst Posted
Study publicly available on registry
October 26, 2010
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedSeptember 30, 2015
September 1, 2015
10 months
October 25, 2010
September 29, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
prefrontal hyperactivation
recall test of extinction (at D21)
Day 21
Secondary Outcomes (1)
neuropsychological tests
Day 21
Study Arms (6)
1
NO INTERVENTIONSafe voluntary.
2
NO INTERVENTIONpatient with psychotrauma but without PSTD and without any psychiatric trouble at the time of inclusion
3
NO INTERVENTIONpatient with psychotrauma and PTSD (post-traumatic stress disorder) and in full remission at the time of inclusion
4.3
NO INTERVENTIONpatient with psychotrauma and with activ PTSD (post-traumatic stress disorder)at the time of inclusion
4.2
SHAM COMPARATORpatient with psychotrauma and with activ PTSD (post-traumatic stress disorder)at the time of inclusion
4.1
EXPERIMENTALpatient with psychotrauma and with activ PTSD (post-traumatic stress disorder)at the time of inclusion
Interventions
patients will be treated with rTMS at 10 Hz (D3 to D7 and D10-D14, 1 session / day)
patients will be treated with rTMS at 10 Hz (D3 to D7 and D10-D14, 1 session / day with the stimulator on off
Eligibility Criteria
You may qualify if:
- French mother tongue
- major
- patient out of hospital
- patient with health insurance
You may not qualify if:
- patient with dysthymia
- alcohol dependence, drug dependence
- acute or chronic psychosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de Nice
Nice, 06000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michel BENOIT, PhD
psychiatry department, Nice University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2010
First Posted
October 26, 2010
Study Start
November 1, 2011
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
September 30, 2015
Record last verified: 2015-09